Misoprostol remains safe and effective for medication abortion
Updated
Updated · NPR · May 4
Misoprostol remains safe and effective for medication abortion
13 articles · Updated · NPR · May 4
A federal appeals court temporarily restricted nationwide telemedicine access to mifepristone, leaving misoprostol as an available option for ending early pregnancy.
The ruling affects how patients obtain the two-drug regimen, but misoprostol-only abortion care remains a medically accepted alternative.
The decision could reshape abortion access across the US as legal battles continue over medication abortion and remote prescribing.
With a key abortion pill restricted, how safe is the remaining single-drug alternative now offered to patients?
A court just overruled FDA scientists on a key drug. What does this mean for the regulation of other medicines?
In 2023, a federal judge in Texas ruled that the FDA improperly approved mifepristone, threatening its availability and disrupting mail-order and telehealth abortion access. This legal uncertainty forced healthcare providers and advocates to shift toward misoprostol-only protocols as a safe alternative. Meanwhile, the 2022 Dobbs decision led to state-level abortion bans, increasing self-managed abortions and making telehealth responsible for one in four U.S. abortions by 2024. In response to these restrictions, some states criminalize abortion medication use outside clinics, while others enacted shield laws to protect providers. These challenges have driven abortion funds to expand support, helping people navigate legal and logistical barriers to safe abortion care.